Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Euclidean Capital LLC
Form 13F · Q2 2026

Euclidean Capital LLC

CIK 1825034Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$440M
Reported book value
11
Positions
12
Quarters on record
Top 50
Positions

Euclidean Capital LLC — holdings

Top 11 positions of 11, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1VANGUARD INTL EQUITY INDEX F Vanguard Intl Equity Index F3.2M+0.0%$272M61.8%
2VTV Vanguard Index Fds520,000+0.0%$113M25.8%
3ISHARES TR Ishares Tr369,600+0.0%$18M4.2%
4ORIC Oric Pharmaceuticals Inc989,410+0.0%$11M2.4%
5TMS Teamshares Inc1.1M—$9M2.1%
6FHTX Foghorn Therapeutics Inc1.6M+0.0%$8M1.7%
7PMVP Pmv Pharmaceuticals Inc2.6M+0.0%$4M0.8%
8ALEC Alector Inc1.3M+0.0%$3M0.6%
9SRZN Surrozen Inc87,696+0.0%$2M0.5%
10TNYA Tenaya Therapeutics Inc1.0M+0.0%$750,7080.2%
11SRZN Surrozen Inc170,833+0.0%$2,8190.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.